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Introduction
Caffeine (1,3,7-trimethylxanthine) is a widely consumed 
purine alkaloid that occurs in numerous dietary sources, 
such as tea, coffee, and soft drinks. Although the U.S. 
Food and Drug Administration lists caffeine as a generally 
recognized safe food substance with multiple purposes, 
overuse of caffeine may have adverse effects, especially for 
pregnant women. In humans, caffeine can pass through 
the placenta to the fetus. There is growing, but conflicting, 
evidence demonstrating that maternal caffeine intake 
can have adverse effects on fetal development (Browne, 
2006; Bakker et al., 2010; Brent et al., 2011). For example, 
pregnant women with higher caffeine intake have been 
reported to be associated with a higher risk of spontane-
ous abortion, late miscarriage, and stillbirth (Christian 
and Brent, 2001). In rats, caffeine has been reported to 
induce cardiovascular malformations (Matsuoka et al., 
1987). In zebrafish, caffeine treatment led to some neuro-
muscular defects and, consequently, caused movement 
disorder (Chen et al., 2008). These observations indicated 
that caffeine has potential embryotoxic and teratogenic 
effects on human and other animal species.
In medical applications, caffeine has been reported to 
interact with ryanodine receptors (RyRs) and adenosine 
receptors (ADRs) (Tsai and Barish, 1995; Huang et al., 
2005). RyRs and ADRs are abundant in muscles as well 
as the nervous and cardiovascular systems; they play 
roles in regulating intracellular calcium release, coronary 
blood flow, and angiogenesis (Fredholm et al., 1997). 
Although we will be focusing on the potential harmful 
effects of caffeine, other studies have noted therapeutic 
RESEARCH ARTICLE
Caffeine treatment disturbs the angiogenesis of  
zebrafish embryos
Chien-Hung Yeh1, Yun-Feng Liao2, Chao-Yuan Chang3, Jen-Ning Tsai4, Yun-Hsin Wang5 , 
Chien-Chung Cheng6, Chi-Chung Wen7, and Yau-Hung Chen1,2
1Graduate Institute of Life Sciences, Tamkang University, Tamsui, New Taipei City, Taiwan, 2Department of Chemistry, 
Tamkang University, Tamsui, New Taipei City, Taiwan, 3Department of Chemical and Materials Engineering, Tamkang 
University, Tamsui, New Taipei City, Taiwan, 4School of Medical Laboratory and Biotechnology, Chung Shan Medical 
University, Taichung, Taiwan, 5Division of Basic Research, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan, 
6Department of Applied Chemistry, National Chia-Yi University, Chia-Yi, Taiwan, and 7Department of Mathematics, 
Tamkang University, New Taipei City, Taiwan 
Abstract
Caffeine is a widely consumed substance that occurs in numerous dietary sources, but teratogenic effects of caffeine 
intake during embryonic development are still not clear. In the present study, we used the zebrafish as a model 
to assess caffeine-induced toxicity on embryonic vascular development. A green fluorescent vascular endothelium 
transgenic line, Tg(fli1:egfp), was utilized for the sensitive detection of vascular development, including vasculo- 
and angiogenesis. Caffeine-treated embryos showed no defects in vasculogenesis, but revealed dose-dependent 
(250–350 ppm) developmental defects in intersegmental vessels, dorsal longitudinal anastomotic vessels, and 
subintestinal vein sprouting. Further, real-time polymerase chain reaction analysis of caffeine-treated embryos 
showed an upregulation of nrp1a along with a downregulation of sema3aa and sema3c. In conclusion, caffeine 
treatment induces defects of angiogenesis in zebrafish embryos.
Keywords: Angiogenesis, caffeine, fluorescent protein, transgenic fish, zebrafish
Address for Correspondence: Yau-Hung Chen, Department of Chemistry, Tamkang University, 151 Ying-chuan Road, Tamsui, New Taipei 
City 25137, Taiwan; Fax: 886-2-2620-9924; E-mail: yauhung@mail.tku.edu.tw
(Received 09 August 2011; revised 10 September 2011; accepted 13 September 2011)
Drug and Chemical Toxicology, 2012; 35(4): 361–365
© 2012 Informa Healthcare USA, Inc.
ISSN 0148-0545 print/ISSN 1525-6014 online
DOI: 10.3109/01480545.2011.627864































































































362 C.-H. Yeh et al.
 Drug and Chemical Toxicology
uses of caffeine through interaction with the RyR and 
ADR receptors (Jacobson and Gao, 2006).
Angiogenesis is a process in which new capillaries are 
formed by sprouting from the primary vascular plexus 
(Risau, 1997). Angiogenesis is conserved between species 
and occurs not only during embryogenesis, but also dur-
ing pathogenesis of adult organs. Several animal models 
have been utilized to assay angiogenesis, such as chick 
chorioallantoic membrane, Matrigel plug, corneal micro-
pocket assay, and zebrafish embryos (Norrby, 2006). The 
primary vasculature in the zebrafish, as in other verte-
brates, is generated by vasculogenesis (i.e., the formation 
of blood vessels from endothelial precursor cells called 
angioblasts). Trunk circulation of zebrafish embryo 
begins at approximately 24–26 hpf (Fouquet et al., 1997; 
Isogai et al., 2001). Subsequent sprouting and branch-
ing of blood vessels is formed by angiogenesis (i.e., the 
formation of new blood vessels from preexisting vessels). 
During embryonic angiogenesis, the intersegmental ves-
sels (Se) are subsequently formed by angiogenic sprout-
ing from dorsal aorta to the dorsal side of the trunk, and 
mature Se consequently form dorsal longitudinal anato-
motic vessels (DLAVs).
In this study, we used the zebrafish model to assess the 
caffeine-induced effects on vascular development (espe-
cially on angiogenesis). The subtle changes of vascular 
development were easily observed by using the green-
fluorescent–vascular endothelium line, Tg(fli1:egfp) 
(Lawson and Weinstein, 2002), as well as using his-
tochemical staining of alkaline phosphatase (ALP) activ-
ity. Further, the molecular mechanisms underlying the 




Tg(fli1:egfp) zebrafish were obtained from the Zebrafish 
International Resource Center, University of Oregon 
(Eugene, Oregon, USA) (Lawson and Weinstein, 
2002). Both wild-type (WT; AB strain) and Tg(fli1:egfp) 
zebrafish were kept under a 14-hour light and 10-hour 
dark photoperiod at 28.5°C. The procedures for zebrafish 
culture, embryo collection, and fluorescence observa-
tion have been described previously (Chen et al., 2007). 
Designation of zebrafish developmental stages was done 
by following the standard criteria (Kimmel et al., 1995). 
All animal experiments in this study were performed in 











; Sigma-Aldrich, St. Louis, Missouri, 
USA) was dissolved in sterile, distilled water to the desired 
concentrations. Three caffeine exposure methods were 
designed using different exposure onsets and durations 
(method I: 0–24 hpf; method II: 12–36 hpf; and method 
III: 12–60 hpf). For dose-titration experiments, zebrafish 
embryos were collected and randomly divided into the 
desired groups. Each group was cultivated in 24-well 
microplates and exposed to either water (mock-control) 
or water containing caffeine of the desired concentra-
tions (250 and 350 ppm). All embryos were counted for 
the number of somites, as well as fully connected DLAVs 
at the exposure checkpoint (24, 36, or 60 hpf).
Quantification of DLAV growth
Zebrafish embryos were anesthetized by 0.006% tricaine 
(Sigma-Aldrich) and photographed under a fluorescence 
stereomicroscope (Leica Microsystems Inc., Buffalo 
Grove, New York, USA), equipped with a green fluores-
cent protein filter set (Chroma Technology Corp., Bellows 
Falls, Vermont, USA). Acquired images were analyzed 
using Image-Pro Plus software (Media Cybernetics Inc., 
Bethesda, Maryland, USA). To get a better quantitative 
view of how caffeine affected DLAVs, we defined “DLAV 
number” in this study. In brief, DLAV number means the 
number of somites containing fully connected DLAVs. In 
this study, a field comprising 10 somites of each embryo, 
in both anterior and posterior portions relative to the 
caudal end of the yolk extension (Figure 1A), was photo-
graphed at multiple focal planes. The number of somites 
containing fully connected DLAVs (i.e., DLAV number) 
was subsequently counted on both lateral sides of each 
embryo (i.e., 20 somites were examined per embryo).
Whole-mount ALP staining
Endogenous ALP activity of WT embryos were stained 
according to standard procedures (Habeck et al., 2002; 
Serbedzija et al., 1999). In brief, embryos were fixed at 3 
dpf in 4% paraformaldehyde in phosphate-buffered saline 
(PBS) for 30 minutes. Fixed embryos were dehydrated 
in methanol, permeabilized in acetone (30 minutes at 
−20°C), and washed in PBST (PBS with 0.1% Tween-20) 
twice. Embryos were equilibrated in staining buffer (0.1 M 
of Tris-HCl [pH 9.5], 50 mM of MgCl
2
, 0.1 M of NaCl, and 
0.1% Tween-20) for 45 minutes. Staining reaction was 
started by adding 2.25 μL of nitro blue tetrazolium (NBT) 
and 1.75 μL of 5-bromo-4-chloro-3-indolyl phosphate 
(BCIP) per mL of staining buffer for 15–30 minutes (stock 
solutions: 75 mg/mL of NBT in 70% dimethylformamide; 
and 50 mg/mL of BCIP in dimethylformamide), then 
stopped by adding PBST.
Quantitative reverse-transcription polymerase chain 
reaction (qRT-PCR)
Total RNAs from each group of zebrafish embryos were 
extracted and reverse-transcribed by using the standard 
procedure, as described previously (Chen et al., 2009; 
Wang et al., 2009). Gene-specific PCR primer sequences 
are listed in Table 1. qPCR was performed by the follow-
ing conditions: 2 minutes at 50°C, 10 minutes at 95°C, 40 
cycles of 15 seconds at 95°C, and 1 minute at 60°C, using 2× 
Power SYBR Green PCR Master Mix (Applied Biosystems, 
Foster City, California, USA) and 200 nM of forward and 
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run in triplicate on a 7300 real-time PCR system (Applied 
Biosystems). Relative fold changes of expression were 
derived using the comparative C
T
 method, and β-actin 
was used as an endogenous control.
Statistical analysis
All analyses in this study were carried out by JMP statisti-
cal software (version 4.02; SAS Institute, Inc., Cary, North 
Carolina, USA). Dosage and exposure-time effects were 
examined by a generalized linear regression model. A 
P-value less than 0.05 was considered statistically signifi-
cant in all analyses.
Results
To investigate the effect of caffeine on vasculo- and 
angiogenesis during early embryonic development, we 
treated transgenic Tg(fli1:egfp) zebrafish with caffeine 
using different exposure methods (method I: 0–24 hpf; 
method II: 12–36 hpf; and method III: 12–60 hpf ). The 
vasculogenesis of zebrafish embryos was not affected 
after caffeine exposure at early stages (method I: 0–24 
hpf; data not shown), but the development of Se and 
DLAVs was disturbed in caffeine-treated embryos at 
later stages (Figure 1; method II: 12–36 hpf; method III: 
12–60 hpf ). The vascular development of embryos was 
thus examined at 36 and 60 hpf. Compared with mock 
control (0 ppm of caffeine; Figure. 2A and D), caffeine 
disturbed the formation of Se in the somite boundar-
ies (Figure 2B, C, E, and 2F). The angiogenic sprouting 
from dorsal aorta to the dorsal side of the trunk was 
prematurely stalled upon caffeine treatment, leading to 
incomplete formation of the Se.
Not only Se formation was disturbed, but caffeine 
also significantly affected DLAV development. Thus, 
we defined “DLAV number” to get a better quantita-
tive view for studying how caffeine affected DLAV 
formation. To study dosage and time effects of caffeine 
exposure on DLAV number, we treated zebrafish 
embryos with three dosages, including 0, 250, and 
300 ppm under two exposure protocols (method II: 
12–36 hpf; method III: 12–60 hpf ). The number of 
embryos tested in each dosage group for methods II 
and III were 60 and 50, respectively. We first depicted, 
in Figure 2, the mean number of DLAVs with its stan-
dard error (SE) for each dosage level under two expo-
sure methods. It can be observed, in Figure 3, that the 
average DLAV numbers decreased significantly from 
19.42 ± 0.13 (mean ± SE) and 8.18 ± 0.30 to 4.65 ± 0.28 
when embryos were treated with 0, 250, and 350 ppm 
of caffeine under method II. A similar phenomenon 
was also observed from method III: Approximately 
19.62 ± 0.12, 8.38 ± 0.37, and 3.64 ± 0.36 DLAV numbers 
arose for 0, 250, and 350 ppm. However, no apparent 
difference in average DLAV number was observed 
for each dosage level between exposure methods. 
Next, we used generalized linear regression analysis 
to examine the dosage and exposure-time effect on 
DLAV number. Results from JMP showed that the dos-
age and exposure-time effects were−4.40 (SE = 0.08; 
P < 0.0001) and−0.20 (SE = 0.23; P = 0.3701) respectively. 
Figure 1. Development of DLAVs in caffeine-treated Tg(fli1:egfp) embryos. Embryos were treated with caffeine (0, 250, or 350 ppm) using 
method II (12–36 hpf ) or III (12–60 hpf ). Images of each embryo were acquired at the developmental stage of 36 or 60 hpf. YE, yolk extension; 
UO, urogenital opening.
Table 1. Primers used in this study.
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The former significantly indicates approximately 4.40 
DLAV number decreases when one more 100 ppm of 
concentration increases, whereas the latter means no 
significant difference in DLAV number between two 
exposure methods.
To confirm whether the effect of caffeine was direct 
or indirect (e.g., muscle development), we observed the 
development of the subintestinal vein (SIV) in caffeine-
treated embryos (Figure 3). After being treated with 
caffeine (250 and 350 ppm, respectively) from 12 to 60 
hpf, the SIV of each embryo was observed at 72 hpf. The 
SIV basket with fully connected lumen appeared in the 
mock-control embryos (Figure 3A). After caffeine treat-
ment, the SIV basket with fully connected lumen was 
strongly reduced or absent (Figure 3B). Interrupted 
and reduced branches of SIV spanning the yolk were 
observed in caffeine-treated embryos. Consistently, 
such caffeine-induced defects in SIV formation were 
also revealed in WT embryos using ALP staining (Figure 
3C and D).
The molecular mechanism of caffeine-induced defects 
in angiogenesis was further investigated by real-time PCR in 
the caffeine-treated groups (Figure 4). We examined three 
target genes involved in vertebrate blood vessel formation: 
neuropilin 1a (nrp1a), semaphoring 3aa (sema3aa), and 
semaphoring 3c (sema3c). Nrp1a is a coreceptor for vascu-
lar endothelial growth factor receptor and Plexin. Nrp1a/
Plexin is the receptor of semaphoring 3A (SEMA3A), 
which is considered to be a proangiogenic factor, whereas 
SEMA3C has been shown to have antiangiogenesis prop-
erties (Gu et al., 2003; Moriya et al., 2010). The messenger 
RNA (mRNA) level of nrp1a in the caffeine-treated group 
was significantly increased to 6.42 (P < 0.05) by fold change, 
compared to the corresponding mock-control group. On 
the other hand, mRNA levels of sema3aa and sema3c in 
the caffeine-treated group were significantly decreased to 
0.44 (P < 0.05) and 0.45 (P < 0.05) by fold change, compared 
to the corresponding mock-control group. These observa-
tions revealed that caffeine affected angiogenesis through 
mediation of the factor for proangiogenic factors (sema3aa 
and sema3c) and coreceptor (nrp1a). These regulatory 
mechanisms may explain why the caffeine-induced defects 
in angiogenic sprouting could be partially restored after the 
interruption of caffeine treatment.
Discussion
In this study, we found that a dosage of 250–350 ppm of 
caffeine is able to disturb the angiogenesis of zebrafish 
embryos. In this regard, comparison of the caffeine dose 
between this study (250–350 ppm) and dietary intake is 
an important issue that should be discussed. The average 
weight of each zebrafish embryo is ~1.2 mg. After appro-
priate calculation, 250–350 ppm of caffeine is estimated 
to be 4,200–5,800 mg/kg (Chen et al., 2008). This range is 
much higher than the acceptable daily intake of caffeine 
in adult people (150–300 mg per day) (Christian and Brent, 
Figure 3. Effects of caffeine on the formation of the SIV. (A) SIV of Tg(fli1:egfp) embryos. (B) caffeine-treated. (C and D) ALP staining of WT 
embryos: (C) no-treatment control versus (D) with caffeine treatment. Caffeine-treated embryos were exposed to 350 ppm of caffeine from 
12 to 60 hpf. All embryos were observed at the developmental stage of 72 hpf.
Figure 2. Number of DLAVs (DLAV number) in caffeine-treated 
Tg(fli1:egfp) embryos. Embryos were treated with caffeine (0, 150, 
250, or 350 ppm) using (A) method II (12–36 hpf ) or (B) method 
III (12–60 hpf ). DLAV number of each embryo was counted at the 
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2001), but very close to the doses (250–8,100 mg) that were 
used to study caffeine-induced toxicities in other animal 
models (Nolen, 1981). Thus, we suggest that daily intake 
of caffeine should not cause angiogenesis defects.
From the molecular aspect, caffeine acts as an antago-
nist against ADRs. There is growing evidence that ADRs 
play an important role in angiogenesis and wound heal-
ing (Feoktistov et al., 2009; Fredholm, 2010; Jacobson 
and Gao, 2006). It is reported that activation of the ADRs 
promotes angiogenesis by increasing the release of 
angiogenic factors (Linden, 2005). Moreover, the caffeine-
induced defects in angiogenesis were partially restored 
after the interruption of caffeine treatment, suggesting 
that such defects may lead to the release of angiogenic 
factors to overcome the disturbance from caffeine.
Conclusion
In conclusion, our results revealed that caffeine influ-
ences vascular development in zebrafish embryos, 
including defects in Se, DLAV, and SIV. Further, we have 
implicated the roles of nrp1a, sema3aa, and sema3c in 
mediating the antiangiogenesis effects of caffeine. This 
could provide novel insights into the subtle changes 
induced by caffeine, which are worthy of further tests, in 
higher vertebrates.
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: cycles of qPCR; relative folds to 
control group = 2−ΔΔCT; the caffeine-treated group is significantly 
different from the corresponding mock group).
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